Evaluating the implementation of the 13-valent pneumococcal vaccine supplementary dose program in Australian primary health care settings

BACKGROUND: The availability of new pneumococcal conjugate vaccines covering a broader range of serotypes, has seen many countries introduce these into their national immunisation program. When transitioning from 7-valent to 13-valent pneumococcal conjugate vaccines, Australia is one of a small numb...

Descripción completa

Detalles Bibliográficos
Autores principales: Ward, Kirsten F, Trent, Marianne, Hull, Brynley P, Quinn, Helen E, Dey, Aditi, Menzies, Robert I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404082/
https://www.ncbi.nlm.nih.gov/pubmed/25889782
http://dx.doi.org/10.1186/s12913-015-0738-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404082/
https://www.ncbi.nlm.nih.gov/pubmed/25889782
http://dx.doi.org/10.1186/s12913-015-0738-y

Ejemplares similares